Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β are implicated in the development of obesity-related systemic inflammation and NAFLD [23], [24]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.